Validity of the General Practice Research Database

Pharmacotherapy

Volumn 23, Issue 5, 2003, Pages 686-689

  Jick, Susan S ^a   Kaye, James A ^a   Vasilakis Scaramozza, Catherine ^a   García Rodríguez, Luis A ^b   Ruigómez, Ana ^b   Meier, Christoph R ^c   Schlienger, Raymond G ^c   Black, Corri ^d   Jick, Hershel ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Ctro Espanol Invest Farmacoepidem ^*  (Spain)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; RUBELLA VACCINE; STATIN; TAMOXIFEN;

AUTISM; BREAST CANCER; CATARACT; CLINICAL RESEARCH; COLORECTAL CANCER; COMPUTER; DATA BASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DRUG SAFETY; EPIDEMIOLOGICAL DATA; GENERAL PRACTICE; HORMONE SUBSTITUTION; HUMAN; INFLUENZA; INFORMATION PROCESSING; INTERMETHOD COMPARISON; INTUSSUSCEPTION; MEDICAL PRACTICE; MEDICAL RECORD; PRESCRIPTION; QUESTIONNAIRE; REVIEW; SCIENTIFIC LITERATURE; UNITED KINGDOM;

DATABASES, FACTUAL; EPIDEMIOLOGIC STUDIES; FAMILY PRACTICE; GREAT BRITAIN; HUMANS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; QUALITY CONTROL; RESEARCH;

EID: 0038305571     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.5.686.32205     Document Type: Review

References (28)

1. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-8.
2. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992;1:347-9.
3. Kaye JA, Derby LE, Melero-Montes MM, Quinn M, Jick H. The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data. Br J Cancer 2000;83:1556-8.
4. Meier CR, Napalkov PN, Wegmueller Y, Jefferson I, Jick H. A population-based study on incidence and risk factors for influenza and its clinical complications in the United Kingdom. Eur J Clin Microbiol Infect Dis 2000;19:834-42.
5. Jick H, Vasilakis-Scaramozza C, Jick SS. Live attenuated polio vaccine and the risk of intussusception. Br J Clin Pharmacol 2001;52:451-3.
6. Kaye JA, Melero-Montes MM, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 2001;322:460-3.
7. García-Rodriguez LA, Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 2001;12:88-93.
8. Ruigómez A, García-Rodríguez LA, Dev VJ, Arellano F, Raniwala J. Are schizophrenia or antipsychotic drugs a risk factor for cataracts? Epidemiology 2000;11:620-3.
9. Jick H, Withers JM, Dean AD. Haemophilus influenzae vaccine [letterl. Br J Gen Pract 1995;45:107.
10. Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ 1995;310:215-18.
11. Jick H, Derby LE, Gurewich V, Vasilakis C. The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension. Pharmacotherapy 1996;16:321-6.
12. Jick SS, Terris BZ. Anticonvulsants and congenital malformations. Pharmacotherapy 1997;17:561-4.
13. Jick H, Jick SS, Derby LE, Vasilakis C, Myers MW, Meier CR. Calcium channel blockers and risk of cancer. Lancet 1997;349:525-8.
14. Derby LE, Maier WC. Risk of cataract among users of intranasal corticosteroids. J Allergy Clin Immunol 2000;105:912-16.
15. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995;346:1589-93.
16. World Health Organization. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolism. Collaborative study of cardiovascular disease and steroid hormone contraception. Lancet 1995;346:1582-8.
17. Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995;346:1593-6.
18. García Rodríguez LA, Jick H. The risk of upper gastrointestinal bleeding and/or perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994;343:769-72.
19. Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075-8.
20. Pérez Gutthann S, Garcia Rodriguez LA, Castellsague J, Duque Oliart A. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. BMJ 1997;314:796-800.
21. Daly E, Vessey MP, Hawkins MH, Carson JL, Gough P, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996;348:977-80.
22. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: no epidemiologic evidence for a causal association. Lancet 1999;353:2026-9.
23. Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H. HMG-CoA reductase inhibitors and the risk of fractures. JAMA 2000;283:3205-10.
24. Wang PS, Solomon DH, Mogun H, Avorn J. HMG-CoA reductase inhibitors and the risk of hip fracture in elderly patients. JAMA 2000;283:3211-16.
25. Chan KA, Andrade SE, Boles M, et al. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet 2000;355:2185-8.
26. Vainio H, Morgan G, Kleihues P. An international evaluation of the cancer-preventive potential of non-steroidal anti-inflammatory drugs. Cancer Epidemiol Biomarkers Prev 1997;6:749-53.
27. Meier CR, Jick H. Tamoxifen and risk of idiopathic venous thromboembolism. Br J Clin Pharmacol 1998;45:608-12.
28. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 1998;90:1371-88.